Why toxins!

Seminars in Cancer Biology

Volumn 7, Issue 2, 1996, Pages 87-95

  Fitzgerald, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Immunotoxin; Receptor endocytosis; Toxin; Translocation

Indexed keywords

IMMUNOTOXIN; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN;

ANTIBODY COMBINING SITE; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG TARGETING; NONHUMAN; REVIEW;

EID: 0029918343     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0013     Document Type: Review

References (67)

1. Yamaizumi M, Makada E, Uchida T, Okada Y (1978). One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 15:245-250
2. Pastan IH, Pai LH, Brinkmann U, Fitzgerald DJ (1995) Recombinant toxins: new therapeutic agents for cancer. Ann NY Acad Sci 758:345-354
3. Pastan I, Chaudhary V, FitzGerald DJ (1992) Recombinant toxins as novel therapeutic agents. Annu Rev Biochem 61:331-354
4. Greenfield L, Johnson VG, Youle RJ (1987) Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity. Science 238:536-539
5. Murphy JR, Bishai W, Borowski M, Miyanohara A, Boyd J, Nagle S (1986) Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related a melanocyte hormone fusion protein. Proc Natl Acad Sci USA. 83:8258-8262
6. Piatak M, Lane JA, Laird W, Bjorn MJ, Wang A, Williams M (1988) Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive. J Biol Chem 263:4837-4843
7. Sehnke PC, Pedrosa L, Paul AL, Frankel AE, Ferl RJ (1994) Expression of active, processed ricin in transgenic tobacco. J Biol Chem 269:22473-22476
8. Li M, Dyda F, Benhar I, Pastan I, Davies DR (1995) The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin. Proc Natl Acad Sci USA 92:9308-9312
9. Brandhuber BJ, Allured VS, Falbel TG, McKay DB (1988) Mapping the enzymatic active site of Pseudomonas aeruginosa Exotoxin A. 3:146-154
10. Allured VS, Collier RJ, Carroll SF, McKay DB (1986) Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Angstrom. Proc Natl Acad Sci 83:1320-1324
11. Bennett MJ, Eisenberg D (1994) Refined structure of monomeric diphtheria toxin at 2.3 A resolution. Protein Sci 3:1464-1475
12. Bennett M, Choe JS, Eisenberg D (1994) Refined structure of dimeric diphtheria toxin at 2.0 A resolution. Protein Sci 3:1444-1463
13. Choe S, Bennett MJ, Fujii G, Kantardjieff KA, Collier RJ, Eisenberg D (1992) The crystal structure of diphtheria toxin. Nature 357:216-222
14. Montfort W, Villafranca JE, Monzingo AF, Ernst SR, Katzin B, Rutenber E, Xuong NH, Hamlin R, Robertus JD (1987) The three-dimensional structure of ricin at 2.8 A. J Biol Chem 262:5398-5403
15. Katzin BJ, Collins EJ, Robertus JD (1991) Structure of ricin A-chain at 2.5 A resolution. Proteins: Struct Funct Genet 10:251-259
16. Rutenber E, Robertus JD (1991) Structure of ricin B-chain at 2.5 A resolution. Proteins: Struct Funct Genet 10:260-269.
17. Esworthy RS, Neville DJ (1984) A comparative study of ricin and diphtheria toxin-antibody-conjugate kinetics on protein synthesis inactivation. J Biol Chem 259:11496-11504
18. FitzGerald DJ (1987) Construction of immunotoxins using Pseudomonas exotoxin A. Meth Enzymol 151:139-145
19. Theuer CP, Kreitman RJ, FitzGerald DJ, Pastan I (1993) Immunotoxins made with a recombinant form of Pseudomonas exotoxin A that do not require proteolysis for activity. Cancer Res 53:340-347
20. O'Hare M, Brown AN, Hussain K, Gebhardt A, Watson G, Roberts LM, Vitetta ES, Thorpe PE, Lord JM (1990) Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence. FEBS Lett 273:200-204
21. Kihara A, Pastan I (1994) Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice. Cancer Res 54:5154-5159
22. Prior TI, FitzGerald DJ, Pastan I (1991) Barnase toxin: a new chimeric toxin composed of pseudomonas exotoxin A and barnase Cell 64:1017-1023
23. Donnelly JJ, Ulmer JB, Hawe LA, Friedman A, Shi XP, Leander KR, Shiver JW, Oliff AI, Martinez D, Montgomery D (1993) Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. Proc Natl Acad Sci USA 90:3530-3534
24. Wang QC, Pai LH, Debinski W, FitzGerald DJ, Pastan I (1993) Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin. Cancer Res 53:4588-4594
25. Trowbridge IS (1991) Endocytosis and signals for internalization [published erratum appears in Curr Opin Cell Biol 1991 Dec; 3:1062]. Curr Opin Cell Biol 3:634-641
26. Zdanovsky AG, Chiron MF, Pastan I, FitzGerald DJ (1993) Mechanism of action of pseudonomonas exotoxin: identification of a rate-limiting step. J Biol Chem 268:21791-21799
27. Pelham HRB, Roberts LM, Lord JM (1992) Toxin entry: how reversible is the secretory pathway? Trends Cell Biol 2:183-185
28. Chaudhary VK, Jinno Y, FitzGerald D, Pastan I (1990) Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc Natl Acad Sci USA 87:308-312
29. Seetharam S, Chaudhary VK, FitzGerald D, Pastan I (1991) Increased cytotoxic activity of pseudomonas exotoxin and two chimeric toxins ending in KDEL. J Biol Chem 266:17376-17381
30. Wales R, Chaddock JA, Roberts LM, Lord JM (1992) Addition of an ER retention signal to the ricin A chain increases the cytotoxicity of the holotoxin. Exp Cell Res 203:1-4
31. Wales R, Roberts LM, Lord JM (1993) Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells. J Biol Chem 268:23986-23990
32. Sandvig K, Olsnes S (1980) Diphtheria toxin entry into cells is facilitated by low pH. J Cell Biol 87:828-832
33. Draper RK, Simon MI (1980) The entry of diphtheria toxin into the mammalian cell cytoplasm: evidence for lyosomal involvement. J Cell Biol 87:849-854
34. Ryser HJ, Mandel R, Ghani F (1991) Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in Chinese hamster ovary cells. J Biol Chem 266:18439-18442
35. Press OW, Martin PJ, Thorpe PE, Vitetta ES (1988) Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells. J Immunol 141:4410-4417
36. Press OW, Hansen JW, Farr A, Martin PJ (1988) Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes. Cancer Res 48:2249-2257
37. Ghetie M-A, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G, Amlot P, Vitetta ES, Thorpe PE (1988) Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-Cells as potential reagents for in vivo therapy. Cancer Res 48:2610-2617
38. Press OW, Farr AG, Borroz KI, Anderson SK, Martin PJ (1989) Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res 49:4906-4912
39. May RD, Finkelman FD, Wheeler HT, Uhr JW, Vitetta ES (1990) Evaluation of ricin A chain-containing immunotoxins directed against different epitopes on the delta-chain of cell surface-associated IgD on murine B cells. J Immonol 144:3637-3642
40. May RD, Wheeler HT, Finkelman FD, Uhr JW, Vitetta FS (1991) Intracellular routing rather than cross-linking or rate of internalization determines the potency of immunotoxins directed against different epitopes of sIgD on murine B cells. Cell Immunol, in press
41. Shan D, Press OW (1995) Constitutive endocytosis and degradation of CD22 by human B cells. J Immunol 154:4466-4475
42. Appelbaum FR, Matthews DC, Eary JF, Badger CC, Kellogg M, Press OW, Martin PJ, Fisher DR, Nelp WB, Thomas ED (1992) The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. Transplantation 54:829-833
43. Scheinberg DA (1993) Monoclonal antibodies in the treatment of myelogenous leukemias. Cancer Treat Res 64:213-232
44. Youle RJ, Uckun FM, Vallera DA, Colombatti M (1986) Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen. J Immunol 136:93-98
45. Kreitman RJ, Pastan I (1994) Recombinant single-chain immunotoxins against T and B cell leukemias. Leuk Lymphoma 13:1-10
46. Kreitman RJ, Chaudhary VK, Kozak RW, FitzGerald DJ, Waldman TA, Pastan I (1992) Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia. Blood 80:2344-2352
47. Heimbrook DC, Stirdivant SM, Ahern JD, Balishin NL, Patrick DR, Edwards GM, Defeo JD, FitzGerald DJ, Pastan I, Oliff A (1990) Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. Proc Natl Acad Sci USA 87:4697-4701
48. Pai LH, Gallo MG, FitzGerald DJ, Pastan I (1991) Anti-tumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGFa-PE40). Cancer Res 51:2808-2812
49. Bjorn MJ, Groetsema G (1987) Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors. Cancer Res 47:6639-6645
50. Ghetie MA, Tucker AK, Richardson J, Uhr JW, Vitetta ES (1992) The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin. Blood 80:2315-2320
51. Weiner LM, O'Dwyer J, Kitson J, Comis RL, Frankel AE, Bauer RJ, Konrad MS, Groves ES (1989) Phase I evaluation of an antibreast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate. Cancer Res 49:4062-4067
52. Pai LH, Bookman MA, Ozols RF, Young RC, Smith JWI, Longo DL, Frankel A, McClay EF, Howell S, Reed E, Willingham MC, FitzGerald DJ, Pastan I (1991) Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J Clin Oncol, in press
53. Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D, Ghetie V, Uhr J, Thorpe PE (1991) A phase 1 immunotoxin trial in patients with B cell lymphoma. Cancer Res, in press
54. Kounnas MZ, Morris RE, Thompson MR, FitzGerald DJ, Strickland DK, Saelinger CB (1992) The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes pseudomonas exotoxin A. J Biol Chem 267:12420-12423
55. Naglich JG, Metherall JE, Russell DW, Eidels L (1992) Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69:1051-1061
56. Williams DP, Wen Z, Watson RS, Boyd J, Strom TB, Murphy JR (1990) Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. J Biol Chem 265:20673-20677
57. Moehring JM, Inocencio NM, Robertson BJ, Moehring TJ (1993) Expression of mouse furin in a Chinese hamster cell resistant to Pseudomonas exotoxin A and viruses complements the genetic lesion. J Biol Chem 268:2590-2594
58. Chiron MF, Fryling CM, FitzGerald DJ (1994) Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like protease prepared from beef liver. J Biol Chem 269:18167-18176
59. Harley SM, Lord JM (1985) In vitro endoproteolytic cleavage of castor bean lectin precursors. Plant Sci 41:111-116
60. Endo Y, Mitsui K, Motizuki M, Tsurugi K (1987) Mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes: the site and characteristics of the modification in 28S rRNA caused by the toxins. J Biol Chem 262:5908-5912
61. Batra JK, Jinno Y, Chaudhary VK, Kondo T, Willingham MC, FitzGerald DJ, Pastan I (1989) Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin. Proc Natl Acad Sci USA 86:8545-8549
62. Kondo T, FitzGerald D, Chaudhary VK, Adhya S, Pastan I (1988) Activity of immunotoxins constructed with modified pseudomonas exotoxin A lacking the cell recognition domain. J Biol Chem 263:9470-9475
63. Pai LH, Batra JK, FitzGerald DJ, Willingham MC, Pastan I (1991) Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin. Proc Natl Acad Sci USA 88:3358-3362
64. Theuer CP, FitzGerald D, Pastan I (1992) A recombinant form of pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing. J Biol Chem 267:16872-16877
65. Lambert JM, Goldmacher VS, Collinson AR, Nadler LM, Blattler WA (1991) An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use. Cancer Res 51:6236-6242
66. Blythman HE, Casellas P, Gros O, Gros P, Jansen FK, Paolucci F, Pau B, Vidal H (1981) Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature 290:145-146
67. Vitetta ES, Thorpe PE (1991) Immunotoxins containing ricin or its A chain. Semin Cell Biol 2:47-58